Doseology Sciences, Inc. (TSE:MOOD) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Doseology Sciences Inc., a functional mushroom supplement company, has appointed Christopher P. Cherry as the Interim CEO while maintaining his CFO role. This move is part of a broader executive realignment aimed at driving the company’s future expansion. The firm has also bolstered its board with the addition of Zara Kanji and Cary Alexander Kazemi, who bring extensive financial and international business experience, respectively.
For further insights into TSE:MOOD stock, check out TipRanks’ Stock Analysis page.